Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges
1
Drug Delivery & Therapeutics Lab, Dhaka 1212, Bangladesh
2
Department of Chemical Engineering, Loughborough University, Epinal Way, Loughborough LE11 3TU, UK
3
Faculty of Engineering and Science, University of Greenwich, Chatham Maritime, Kent ME4 4TB, UK
4
Department of Pharmacy, Brac University, 66 Mohakhali, Dhaka 1212, Bangladesh
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Academic Editor: Wouter L. J. Hinrichs
Pharmaceutics 2022, 14(5), 1066; https://doi.org/10.3390/pharmaceutics14051066
Received: 19 March 2022
/
Revised: 27 April 2022
/
Accepted: 9 May 2022
/
Published: 16 May 2022
(This article belongs to the Special Issue Recent Advances in Vaccine Delivery)
To prevent the coronavirus disease 2019 (COVID-19) pandemic and aid restoration to prepandemic normality, global mass vaccination is urgently needed. Inducing herd immunity through mass vaccination has proven to be a highly effective strategy for preventing the spread of many infectious diseases, which protects the most vulnerable population groups that are unable to develop immunity, such as people with immunodeficiencies or weakened immune systems due to underlying medical or debilitating conditions. In achieving global outreach, the maintenance of the vaccine potency, transportation, and needle waste generation become major issues. Moreover, needle phobia and vaccine hesitancy act as hurdles to successful mass vaccination. The use of dissolvable microneedles for COVID-19 vaccination could act as a major paradigm shift in attaining the desired goal to vaccinate billions in the shortest time possible. In addressing these points, we discuss the potential of the use of dissolvable microneedles for COVID-19 vaccination based on the current literature.
View Full-Text
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Hassan, J.; Haigh, C.; Ahmed, T.; Uddin, M.J.; Das, D.B. Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges. Pharmaceutics 2022, 14, 1066. https://doi.org/10.3390/pharmaceutics14051066
AMA Style
Hassan J, Haigh C, Ahmed T, Uddin MJ, Das DB. Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges. Pharmaceutics. 2022; 14(5):1066. https://doi.org/10.3390/pharmaceutics14051066
Chicago/Turabian StyleHassan, Jasmin, Charlotte Haigh, Tanvir Ahmed, Md J. Uddin, and Diganta B. Das. 2022. "Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges" Pharmaceutics 14, no. 5: 1066. https://doi.org/10.3390/pharmaceutics14051066
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
